In the fourth test trial in the federal multidistrict litigation over injury claims relating to testosterone replacement medications, drugmaker AbbVie Inc will be allowed to introduce some evidence of the plaintiff’s medical history as part of its defense, the presiding judge ruled on Saturday.
The trial of Robert Nolte and his wife Genienne, who claim Nolte suffered a pulmonary embolism as a result of his treatment with AbbVie’s AndroGel, kicked off at the U.S. District Court for the Northern District of Illinois on Monday.
To read the full story on Westlaw Practitioner Insights, click here: bit.ly/2qEjHEk
 